Clinical Trial Update: Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins

View source ↗

Summary

A completed clinical trial compared the effectiveness and tolerability of once-weekly exenatide with basal insulin regimens in adults with type 2 diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bydureon (exenatide)
• Lantus (insulin glargine)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Status: COMPLETED